Seeing Is Believing
Currently out of the existing stock ratings of Gregory Fraser, 42 are a BUY (85.71%), 7 are a HOLD (14.29%).
Analyst Gregory Fraser, carries an average stock price target met ratio of 41.67% that have a potential upside of 44.13% achieved within 114 days.
Gregory Fraser’s has documented 99 price targets and ratings displayed on 15 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on JAZZ, Jazz Pharmaceuticals PLC at 16-Dec-2024.
Analyst best performing recommendations are on EOLS (EVOLUS).
The best stock recommendation documented was for EOLS (EVOLUS) at 1/20/2022. The price target of $11 was fulfilled within 56 days with a profit of $5.46 (98.56%) receiving and performance score of 17.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
3 years ago
(23-Aug-2022)
0/1 (0%)
$8.35 (228.77%)
Hold
$13
3 years 1 days ago
(22-Aug-2022)
0/1 (0%)
$8.7 (202.33%)
Buy
$10
3 years 3 months 6 days ago
(17-May-2022)
0/1 (0%)
$4.78 (91.57%)
Buy
$12
3 years 4 months 13 days ago
(11-Apr-2022)
0/1 (0%)
$3.91 (48.33%)
Buy
$20
3 years 4 months 13 days ago
(11-Apr-2022)
0/1 (0%)
$11.91 (147.22%)
What Year was the first public recommendation made by Gregory Fraser?